OrthoPediatrics Corp Operating Expenses
OrthoPediatrics Corp (KIDS) reported Operating Expenses of $56.43 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:OperatingExpenses · last filed 2026-08-05
- OrthoPediatrics Corp operating expenses for the quarter ending 2026-06-30 was $56.43M, a 3.22% increase year-over-year.
- OrthoPediatrics Corp operating expenses for the quarter ending 2026-03-31 was $51.73M, a 5.04% increase year-over-year.
- OrthoPediatrics Corp operating expenses for the quarter ending 2025-12-31 was $53.28M, a 7.37% increase year-over-year.
- OrthoPediatrics Corp operating expenses for the quarter ending 2025-09-30 was $54.70M, a 19.89% increase year-over-year.
- OrthoPediatrics Corp operating expenses for fiscal 2025 was $211.90M, a 15.41% increase from fiscal 2024.
- OrthoPediatrics Corp operating expenses for fiscal 2024 was $183.61M, a 33.05% increase from fiscal 2023.
- OrthoPediatrics Corp operating expenses for fiscal 2023 was $138.00M, a 18.91% increase from fiscal 2022.
- OrthoPediatrics Corp operating expenses for fiscal 2022 was $116.06M, a 26.94% increase from fiscal 2021.
| Period end | Operating Expenses 3 month | Operating Expenses 6 month | Operating Expenses 9 month | Operating Expenses 12 month |
|---|---|---|---|---|
| 2026-06-30 | $56.43M 10-Q · filed 2026-08-05 | $108.16M 10-Q · filed 2026-08-05 | $161.44M derived: sum of 3 quarters · filed 2026-08-05 | $216.14M derived: sum of 4 quarters · filed 2026-08-05 |
| 2026-03-31 | $51.73M 10-Q · filed 2026-05-01 | $105.00M derived: sum of 2 quarters · filed 2026-05-01 | $159.71M derived: sum of 3 quarters · filed 2026-05-01 | $214.38M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-12-31 | $53.28M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-04 | $107.98M derived: sum of 2 quarters · filed 2026-03-04 | $162.66M derived: sum of 3 quarters · filed 2026-08-05 | $211.90M 10-K · filed 2026-03-04 |
| 2025-09-30 | $54.70M 10-Q · filed 2025-10-29 | $109.38M derived: sum of 2 quarters · filed 2026-08-05 | $158.62M 10-Q · filed 2025-10-29 | $208.24M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-06-30 | $54.68M 10-Q · filed 2026-08-05 | $103.92M 10-Q · filed 2026-08-05 | $153.54M derived: sum of 3 quarters · filed 2026-08-05 | $199.16M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-03-31 | $49.24M 10-Q · filed 2026-05-01 | $98.86M derived: sum of 2 quarters · filed 2026-05-01 | $144.49M derived: sum of 3 quarters · filed 2026-05-01 | $190.95M derived: sum of 4 quarters · filed 2026-05-01 |
| 2024-12-31 | $49.62M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-04 | $95.25M derived: sum of 2 quarters · filed 2026-03-04 | $141.71M derived: sum of 3 quarters · filed 2026-03-04 | $183.61M 10-K · filed 2026-03-04 |
| 2024-09-30 | $45.63M 10-Q · filed 2025-10-29 | $92.09M derived: sum of 2 quarters · filed 2025-10-29 | $133.99M 10-Q · filed 2025-10-29 | $168.77M derived: sum of 4 quarters · filed 2026-03-04 |
| 2024-06-30 | $46.47M 10-Q · filed 2025-08-06 | $88.36M 10-Q · filed 2025-08-06 | $123.14M derived: sum of 3 quarters · filed 2026-03-04 | $158.60M derived: sum of 4 quarters · filed 2026-03-04 |
| 2024-03-31 | $41.90M 10-Q · filed 2025-05-08 | $76.68M derived: sum of 2 quarters · filed 2026-03-04 | $112.14M derived: sum of 3 quarters · filed 2026-03-04 | $147.75M derived: sum of 4 quarters · filed 2026-03-04 |
| 2023-12-31 | $34.78M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-04 | $70.24M derived: sum of 2 quarters · filed 2026-03-04 | $105.85M derived: sum of 3 quarters · filed 2026-03-04 | $138.00M 10-K · filed 2026-03-04 |
| 2023-09-30 | $35.46M 10-Q · filed 2024-11-07 | $71.07M derived: sum of 2 quarters · filed 2024-11-07 | $103.22M 10-Q · filed 2024-11-07 | $132.76M derived: sum of 4 quarters · filed 2025-03-05 |
| 2023-06-30 | $35.61M 10-Q · filed 2024-08-06 | $67.76M 10-Q · filed 2024-08-06 | $97.30M derived: sum of 3 quarters · filed 2025-03-05 | $130.15M derived: sum of 4 quarters · filed 2025-03-05 |
| 2023-03-31 | $32.15M 10-Q · filed 2024-05-07 | $61.69M derived: sum of 2 quarters · filed 2025-03-05 | $94.53M derived: sum of 3 quarters · filed 2025-03-05 | $123.26M derived: sum of 4 quarters · filed 2025-03-05 |
| 2022-12-31 | $29.53M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-05 | $62.38M derived: sum of 2 quarters · filed 2025-03-05 | $91.11M derived: sum of 3 quarters · filed 2025-03-05 | $116.06M 10-K · filed 2025-03-05 |
| 2022-09-30 | $32.85M 10-Q · filed 2023-11-07 | $61.57M derived: sum of 2 quarters · filed 2023-11-07 | $86.53M 10-Q · filed 2023-11-07 | $110.17M derived: sum of 4 quarters · filed 2024-03-08 |
| 2022-06-30 | $28.72M 10-Q · filed 2023-08-01 | $53.68M 10-Q · filed 2023-08-01 | $77.32M derived: sum of 3 quarters · filed 2024-03-08 | $99.52M derived: sum of 4 quarters · filed 2024-03-08 |
| 2022-03-31 | $24.95M 10-Q · filed 2023-05-02 | $48.59M derived: sum of 2 quarters · filed 2024-03-08 | $70.79M derived: sum of 3 quarters · filed 2024-03-08 | $94.08M derived: sum of 4 quarters · filed 2024-03-08 |
| 2021-12-31 | $23.64M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-08 | $45.84M derived: sum of 2 quarters · filed 2024-03-08 | $69.13M derived: sum of 3 quarters · filed 2024-03-08 | $91.43M 10-K · filed 2024-03-08 |
| 2021-09-30 | $22.20M 10-Q · filed 2022-11-01 | $45.49M derived: sum of 2 quarters · filed 2022-11-01 | $67.78M 10-Q · filed 2022-11-01 | $95.65M derived: sum of 4 quarters · filed 2023-03-01 |
| 2021-06-30 | $23.29M 10-Q · filed 2022-08-04 | $45.59M 10-Q · filed 2022-08-04 | $73.45M derived: sum of 3 quarters · filed 2023-03-01 | $93.58M derived: sum of 4 quarters · filed 2023-03-01 |
| 2021-03-31 | $22.30M 10-Q · filed 2022-05-05 | $50.16M derived: sum of 2 quarters · filed 2023-03-01 | $70.30M derived: sum of 3 quarters · filed 2023-03-01 | $87.37M derived: sum of 4 quarters · filed 2023-03-01 |
| 2020-12-31 | $27.86M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-01 | $48.00M derived: sum of 2 quarters · filed 2023-03-01 | $65.08M derived: sum of 3 quarters · filed 2023-03-01 | $81.79M 10-K · filed 2023-03-01 |
| 2020-09-30 | $20.14M 10-Q · filed 2021-11-04 | $37.22M derived: sum of 2 quarters · filed 2021-11-04 | $53.92M 10-Q · filed 2021-11-04 | $71.41M derived: sum of 4 quarters · filed 2022-03-03 |
| 2020-06-30 | $17.08M 10-Q · filed 2021-08-05 | $33.79M 10-Q · filed 2021-08-05 | $51.27M derived: sum of 3 quarters · filed 2022-03-03 | $68.70M derived: sum of 4 quarters · filed 2022-03-03 |
| 2020-03-31 | $16.71M 10-Q · filed 2021-05-06 | $34.19M derived: sum of 2 quarters · filed 2022-03-03 | $51.63M derived: sum of 3 quarters · filed 2022-03-03 | $67.03M derived: sum of 4 quarters · filed 2022-03-03 |
| 2019-12-31 | $17.48M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-03 | $34.91M derived: sum of 2 quarters · filed 2022-03-03 | $50.32M derived: sum of 3 quarters · filed 2022-03-03 | $63.70M 10-K · filed 2022-03-03 |
| 2019-09-30 | $17.43M 10-Q · filed 2020-11-05 | $32.84M derived: sum of 2 quarters · filed 2020-11-05 | $46.22M 10-Q · filed 2020-11-05 | $58.59M derived: sum of 4 quarters · filed 2021-03-11 |
| 2019-06-30 | $15.41M 10-Q · filed 2020-08-06 | $28.78M 10-Q · filed 2020-08-06 | $41.16M derived: sum of 3 quarters · filed 2021-03-11 | $54.31M derived: sum of 4 quarters · filed 2021-03-11 |
| 2019-03-31 | $13.37M 10-Q · filed 2020-05-06 | $25.75M derived: sum of 2 quarters · filed 2021-03-11 | $38.90M derived: sum of 3 quarters · filed 2021-03-11 | $52.29M derived: sum of 4 quarters · filed 2021-03-11 |
| 2018-12-31 | $12.38M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-11 | $25.53M derived: sum of 2 quarters · filed 2021-03-11 | $38.92M derived: sum of 3 quarters · filed 2021-03-11 | $52.23M 10-K · filed 2021-03-11 |
| 2018-09-30 | $13.15M 10-Q · filed 2019-11-08 | $26.54M derived: sum of 2 quarters · filed 2019-11-08 | $39.85M 10-Q · filed 2019-11-08 | $52.89M derived: sum of 4 quarters · filed 2020-03-05 |
| 2018-06-30 | $13.39M 10-Q · filed 2019-08-13 | $26.70M 10-Q · filed 2019-08-13 | $39.74M derived: sum of 3 quarters · filed 2020-03-05 | $49.99M derived: sum of 4 quarters · filed 2020-03-05 |
| 2018-03-31 | $13.31M 10-Q · filed 2019-05-09 | $26.35M derived: sum of 2 quarters · filed 2020-03-05 | $36.60M derived: sum of 3 quarters · filed 2020-03-05 | $45.99M derived: sum of 4 quarters · filed 2020-03-05 |
| 2017-12-31 | $13.04M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-05 | $23.28M derived: sum of 2 quarters · filed 2020-03-05 | $32.67M derived: sum of 3 quarters · filed 2020-03-05 | $40.92M 10-K · filed 2020-03-05 |
| 2017-09-30 | $10.25M 10-Q · filed 2018-10-31 | $19.64M derived: sum of 2 quarters · filed 2018-10-31 | $27.89M 10-Q · filed 2018-10-31 | $37.54M derived: sum of 4 quarters · filed 2019-03-07 |
| 2017-06-30 | $9.39M 10-Q · filed 2018-08-09 | $17.64M 10-Q · filed 2018-08-09 | $27.29M derived: sum of 3 quarters · filed 2019-03-07 | $34.97M derived: sum of 4 quarters · filed 2019-03-07 |
| 2017-03-31 | $8.25M 10-Q · filed 2018-05-15 | $17.90M derived: sum of 2 quarters · filed 2019-03-07 | $25.58M derived: sum of 3 quarters · filed 2019-03-07 | |
| 2016-12-31 | $9.65M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-07 | $17.33M derived: sum of 2 quarters · filed 2019-03-07 | $32.49M 10-K · filed 2019-03-07 | |
| 2016-09-30 | $7.68M 10-Q · filed 2017-11-13 | $22.84M 10-Q · filed 2017-11-13 | ||
| 2015-12-31 | $28.23M 10-K · filed 2018-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| SS Innovations International, Inc. (SSII) | $0.589B | -64.06 | |
| DELCATH SYSTEMS, INC. (DCTH) | United States | $0.558B | 820.33 |
| ANGIODYNAMICS INC (ANGO) | United States | $0.632B | -13.02 |
| CERUS CORP (CERS) | United States | $0.525B | -86.40 |
| TACTILE SYSTEMS TECHNOLOGY INC (TCMD) | United States | $0.519B | 27.16 |
| MIMEDX GROUP, INC. (MDXG) | United States | $0.687B | 89.92 |
| NeuroPace Inc (NPCE) | United States | $0.480B | -28.52 |
| Sight Sciences, Inc. (SGHT) | United States | $0.478B | -9.95 |
| ClearPoint Neuro, Inc. (CLPT) | United States | $0.446B | -15.74 |
| CARLSMED, INC. (CARL) | United States | $0.405B |